IS5012A - Alendronate Fluid Compositions - Google Patents

Alendronate Fluid Compositions

Info

Publication number
IS5012A
IS5012A IS5012A IS5012A IS5012A IS 5012 A IS5012 A IS 5012A IS 5012 A IS5012 A IS 5012A IS 5012 A IS5012 A IS 5012A IS 5012 A IS5012 A IS 5012A
Authority
IS
Iceland
Prior art keywords
alendronate
fluid compositions
compositions
fluid
alendronate fluid
Prior art date
Application number
IS5012A
Other languages
Icelandic (is)
Inventor
J. Nerurkar Maneesh
A. Hunke William
Ostovic Drazen
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700541.7A external-priority patent/GB9700541D0/en
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of IS5012A publication Critical patent/IS5012A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS5012A 1996-10-04 1999-03-26 Alendronate Fluid Compositions IS5012A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2676596P 1996-10-04 1996-10-04
GBGB9700541.7A GB9700541D0 (en) 1997-01-13 1997-01-13 Liquid alendronate formulation
US3600297P 1997-01-22 1997-01-22
PCT/US1997/015740 WO1998014196A1 (en) 1996-10-04 1997-10-02 Liquid alendronate formulations

Publications (1)

Publication Number Publication Date
IS5012A true IS5012A (en) 1999-03-26

Family

ID=27268667

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5012A IS5012A (en) 1996-10-04 1999-03-26 Alendronate Fluid Compositions

Country Status (20)

Country Link
EP (1) EP1007054A4 (en)
JP (1) JP2001501222A (en)
CN (1) CN1238691A (en)
AU (1) AU723357B2 (en)
BG (1) BG103306A (en)
BR (1) BR9712197A (en)
CA (1) CA2267370A1 (en)
CZ (1) CZ116999A3 (en)
EA (1) EA001213B1 (en)
EE (1) EE03669B1 (en)
HU (1) HUP0000125A3 (en)
IL (1) IL129127A0 (en)
IS (1) IS5012A (en)
NO (1) NO991569L (en)
NZ (1) NZ334836A (en)
PL (1) PL332496A1 (en)
SK (1) SK42999A3 (en)
TR (1) TR199900730T2 (en)
WO (1) WO1998014196A1 (en)
YU (1) YU17499A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002058708A1 (en) * 2001-01-23 2002-08-01 Gador S.A. Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
WO2007031785A2 (en) * 2005-09-16 2007-03-22 Selamine Ltd Bisphosphonate formulation
US7473684B2 (en) 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
JP2010043119A (en) * 2009-10-16 2010-02-25 Gador Sa Composition for preventing and/or treating bone metabolic disease, method of preparing the same and use thereof
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206209A (en) * 1978-11-02 1980-06-03 Kracauer Paul Sublingual aspirin tablet
IT1201087B (en) * 1982-04-15 1989-01-27 Gentili Ist Spa PHARMACOLOGICALLY ACTIVE BIPPHOSPHONES, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
US4922007A (en) * 1989-06-09 1990-05-01 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
US5019651A (en) * 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
US5358941A (en) * 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
FR2703590B1 (en) * 1993-04-05 1995-06-30 Sanofi Elf USE OF BISPHOSPHONIC ACID DERIVATIVES FOR THE PREPARATION OF MEDICINES FOR PROMOTING BONE REPAIR.
US5510517A (en) * 1993-08-25 1996-04-23 Merck & Co., Inc. Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
US5780455A (en) * 1994-08-24 1998-07-14 Merck & Co., Inc. Intravenous alendronate formulations
US5616571A (en) * 1995-06-06 1997-04-01 Merck & Co., Inc. Bisphosphonates prevent bone loss associated with immunosuppressive therapy

Also Published As

Publication number Publication date
EA001213B1 (en) 2000-12-25
EA199900352A1 (en) 1999-08-26
NO991569L (en) 1999-06-04
JP2001501222A (en) 2001-01-30
BR9712197A (en) 1999-08-31
EP1007054A1 (en) 2000-06-14
WO1998014196A1 (en) 1998-04-09
BG103306A (en) 2000-01-31
CN1238691A (en) 1999-12-15
EE03669B1 (en) 2002-04-15
CZ116999A3 (en) 1999-09-15
AU723357B2 (en) 2000-08-24
YU17499A (en) 1999-11-22
EE9900113A (en) 1999-10-15
TR199900730T2 (en) 1999-07-21
CA2267370A1 (en) 1998-04-09
HUP0000125A3 (en) 2001-04-28
NZ334836A (en) 2000-11-24
PL332496A1 (en) 1999-09-13
EP1007054A4 (en) 2000-07-19
IL129127A0 (en) 2000-02-17
NO991569D0 (en) 1999-03-30
HUP0000125A2 (en) 2000-06-28
AU4644897A (en) 1998-04-24
SK42999A3 (en) 2000-01-18

Similar Documents

Publication Publication Date Title
DE69715036D1 (en) FLUID CONNECTIONS
ID22931A (en) HERBISIDAL COMPOSITIONS
DE69803761D1 (en) OIL COMPOSITIONS
DK1298194T3 (en) Staniol-containing compositions
FI974241A0 (en) BPM-15 compositions
ATE242971T1 (en) PESTICIDE COMPOSITIONS
BR9710090A (en) Pesticide compositions
ID17241A (en) PESTICIDE COMPOSITIONS
DE69809982D1 (en) sealant compositions
ID16251A (en) KUMAN EXTENSION COMPOSITIONS
ATE209959T1 (en) MICRO-ENCAPSULED COMPOSITIONS
ATE293672T1 (en) COLOR-FRIENDLY COMPOSITIONS
DE69719442D1 (en) Frisierschaum compositions
DE69611991D1 (en) Brazing fluid
DE69723704D1 (en) PESTICIDE COMPOSITIONS
DE69617029D1 (en) ORGANOTON COMPOSITIONS
ID25650A (en) SAMPO COMPOSITIONS
IS5012A (en) Alendronate Fluid Compositions
DE69702001D1 (en) COATING COMPOSITIONS
DE69826706D1 (en) WÄSCHEWEICH COMPOSITIONS
DK0867470T3 (en) Inulin-based hydrocolloid compositions
DE69815138D1 (en) Phosphonium COMPOSITION
ID23520A (en) FLUID COMPOSITION FLUID WATER
DE69603228D1 (en) Aluminoxanate compositions
MA23731A1 (en) DETEGENT COMPOSITIONS